Cardiogenic hypertrophic osteopathy in a dog with a right-to-left shunting patent ductus arteriosus

Journal of the American Veterinary Medical Association

Volumn 224, Issue 9, 2004, Pages 1464-1466+1453

  Anderson, Timothy P ^a,b   Walker, Mark C ^a   Goring, Robert L ^a  

^a Center for Veterinary Care ^*  (United States)

^b City Veterinary Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ARTICLE; BONE DISEASE; CARDIOGENIC HYPERTROPHIC OSTEOPATHY; CELL PROLIFERATION; CYANOSIS; DISEASE SEVERITY; HEART RIGHT LEFT SHUNT; HEART RIGHT VENTRICLE HYPERTROPHY; HINDLIMB; HYPERTROPHIC OSTEOARTHROPATHY; MALE; NONHUMAN; PATENT DUCTUS ARTERIOSUS; POLYCYTHEMIA VERA; RADIOGRAPHY;

ANIMALS; CARDIOMEGALY; CYANOSIS; DOG DISEASES; DOGS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; HINDLIMB; HYPEROSTOSIS; MALE; OSTEOPATHIC MEDICINE; RADIOGRAPHY, THORACIC;

ANIMALIA; CANIS FAMILIARIS;

EID: 2442543609     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.1464     Document Type: Article

References (23)

1. Goodwin J, Holland M. Contrast echoaortography as an aid in the diagnosis of right-to-left shunting patent ductus arteriosus. Vet Radiol Ultrasound 1995;36:157-159.
2. Bonagura JD, Lehmkuhl LB. Congenital heart disease. In: Fox PR, Sisson D, Molse NS, eds. Textbook of canine and feline cardiology: principles and clinical practice. 2nd ed. Philadelphia: WB Saunders Co, 1999;471-535.
3. Buchanan JW. Patent ductus arteriosus. Semin Vet Med Surg (Small Anim) 1994;9:168-176.
4. Côté E, Ettinger SJ. Long-term management of right-to-left ("reversed") patent ductus arteriosus in 3 dogs. J Vet Intern Med 2001;15:39-42.
5. Moore KW, Stepien RL. Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs. J Vet Intern Med 2001;15:418-421.
6. Campbell KL. Diagnosis and management of polycythemia in dogs. Compend Contin Educ Pract Vet 1990;12:543-550.
7. Halliwell WH, Ackerman N. Botyroid rhabdomyosarcoma of the urinary bladder and hypertrophic osteoarthropathy in a young dog. J Am Vet Med Assoc 1974;165:911-913.
8. Brodey RS. Hypertrophic osteoarthropathy in the dog: a clinicopathologic survey of 60 cases. J Am Vet Med Assoc 1971;159:1242-1256.
9. Craig JA, Helman RG, Walker M. Costal bone changes similar to hypertrophic osteopathy associated with pulmonary and abdominal mesothelioma. J Am Vet Med Assoc 1985;186:1100-1101.
10. Caywood DD, Kramek BA, Feeney DA, et al. Hypertrophic osteopathy associated with a bronchial foreign body and lobar pneumonia in a dog. J Am Vet Med Assoc 1985;186:698-700.
11. Leighton RL, Olson S. Hypertrophic osteoarthropathy in a dog with pulmonary abscess. J Am Vet Med Assoc 1967;150:1516-1520.
12. Martinez-Lavin M, Matucci-Cerinic M, Jajic I, et al. Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993;20:1386-1387.
13. Pineda C, Fonseca C, Martinez-Lavin M. The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy. J Rheumatol 1990;17:626-632.
14. Martinez-Lavin M. Hypertrophic osteoarthropathy. Curr Opin Rheumatol 1997;9:83-86.
15. Martinez-Lavin M. Cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992;10:19-21.
16. Martinez-Lavin M. Pathogenesis of hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992;10:49-50.
17. Martinez-Lavin M, Bobadilla M, Casanova J, et al. Hypertrophic osteoarthropathy in cyanotic congenital heart disease: its prevalence and relationship to bypass of the lungs. Arthritis Rheum 1982;25:1186-1193.
18. Flavell G. Reversal of pulmonary hypertrophic osteoarthropathy by vagotomy. Lancet 1956;1:260-262.
19. Vazquez-Abad D, Martinez-Lavin M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991;9:59-62.
20. Silveira LH, Martinez-Lavin M, Pineda C, et al. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000;18:57-62.
21. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996;271:603-606.
22. Mohle R, Green D, Moore RA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 1997;94:663-668.
23. Midy V, Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994;199:380-386.